lacosamide   Click here for help

GtoPdb Ligand ID: 7472

Synonyms: ADD 234037 | erlosamide | harkeroside | SPM 927 | Vimpat®
Approved drug
lacosamide is an approved drug (EMA and FDA (2008))
Compound class: Synthetic organic
Comment: Lacosamide is a functionalized amino acid anticonvulsant drug [2].
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: lacosamide

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 8
Topological polar surface area 67.43
Molecular weight 250.13
XLogP 0.51
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES COCC(C(=O)NCc1ccccc1)NC(=O)C
Isomeric SMILES COC[C@H](C(=O)NCc1ccccc1)NC(=O)C
InChI InChI=1S/C13H18N2O3/c1-10(16)15-12(9-18-2)13(17)14-8-11-6-4-3-5-7-11/h3-7,12H,8-9H2,1-2H3,(H,14,17)(H,15,16)/t12-/m1/s1
Bioactivity Comments
We have tagged the Nav1.7 voltage-gated sodium channel as the primary target of this drug, simply as this is the only human voltage-gated sodium channel for which we have been able to find affinity data. This does not preclude interaction at other sodium channels.
Selectivity at ion channels
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
Nav1.8 Rn Channel blocker Antagonist 4.8 pIC50 - 3
pIC50 4.8 (IC50 1.6x10-5 M) [3]
Nav1.2 Rn Channel blocker Antagonist 4.5 pIC50 - 1
pIC50 4.5 (IC50 3x10-5 M) [1]
Voltage: -80.0 mV
Nav1.7 Primary target of this compound Hs Channel blocker Antagonist 3.7 pIC50 - 3
pIC50 3.7 (IC50 1.82x10-4 M) [3]
Nav1.3 Rn Channel blocker Antagonist 3.4 pIC50 - 3
pIC50 3.4 (IC50 4.15x10-4 M) [3]